Latest BRCA1 Stories
A New York infertility treatment and research center earns a patent for a unique method of reducing the risk and spread of breast and ovarian cancer in women. New
The global study was led by University of Melbourne and the Peter MacCallum Cancer Centre and published in the Journal of Clinical Oncology today.
Two women have the same genetic mutation – an abnormal BRCA1 gene that puts them both at much higher-than-average risk for breast cancer – but only one woman develops the disease.
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumors are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Fulgent Therapeutics, a CLIA Certified Laboratory, announces today the inclusion of BRCA1 and BRCA2 analysis into its Hereditary Cancer Panel. Temple City, CA
Plaintiffs, including the American Civil Liberties Union, Association for Molecular Pathology, and American Society for Clinical Pathology, win long-fought case against Myriad Genetics, Association
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.